Success Rate of Benign Oral Squamous Papilloma Treatments After Different Surgical Protocols (Conventional, Nd:YAG, CO2 and Diode 980 nm Lasers): A 34-Year Retrospective Study.
Namour, Samir; {"lastName":"Mobadder", "firstNames":"Marwan El","affiliations":["Department of Dental Sciences, Faculty of Medicine, University of Liege, Liege, Belgium"],"ids":["SC:57208147957"}; Namour, Amauryet al.
2021 • In Photobiomodulation, Photomedicine, and Laser Surgery, 39 (2), p. 123 - 130
[en] Objective: The aim of our retrospective study is to compare the long-term recurrence rate of the benign oral squamous papilloma (OSP) with different laser-assisted treatments and conventional procedures (use of scalpels) aiming to suggest the most suitable surgical protocol showing the lowest recurrence rate. Background: A retrospective multicenter DATA collection between 1985 and 2019 covering 781 OSP cases concerning different surgical protocols used for the treatment of OSP was done and included the use of different laser wavelengths [neodymium-doped yttrium-aluminum-garnet (Nd:YAG), carbon dioxide (CO2), and Diode 980 nm] and the conventional surgeries using the scalpel. The age, sex, and the oral location of the OSP were noted. Methods: Three different surgical protocols were selected in our study: protocol 1 regrouped surgical procedures performing the excision of OSP with an in-depth safety margin of 1 mm and just at the base of the tumor with reduced excision of the grossly normal marginal mucosa around the tumor (0-1 mm). Protocol 2 and 3 were similar to protocol 1, but with an additional excision of 1-2 mm and ≥3 mm of the grossly normal marginal mucosa, respectively, for group 2 and 3. All laser-treated OSP wounds were left without sutures. In the conventionally treated OSP, sutures were regularly performed. Follow-up was done after 15 days and at 1, 6, and 18 months. The three included wavelengths were Nd:YAG (1064 nm), CO2 laser (10,600 nm), and diode laser (980 nm). Results: After 18 months of follow-up, the highest success rate was obtained with protocol 3 (100% with Nd:YAG, 99% with CO2, 98.4% with diode, and 99% with the scalpel), which was significantly higher than the values of protocol 2 (96.6% with Nd:YAG, 91% with CO2, 96% with diode, and 95% with the scalpel) and the protocol 1 (38% with Nd:YAG, 29% with CO2, 33% with diode, and 30% with the scalpel). The oral locations of OSP were 30% on palates, 30% on the tongue, 16% on cheek, 14% on lips, and 10% on other locations. Conclusions: The lowest recurrence rate was observed when a minimum of three millimeters (≥3 mm) of grossly normal aspect mucosa around the OSP was included in the excisions. The laser wavelengths and the use of scalpel did not show any significant difference in terms of recurrence.
Disciplines :
Dentistry & oral medicine
Author, co-author :
Namour, Samir ; Université de Liège - ULiège > Département des sciences dentaires
{"lastName":"Mobadder", "firstNames":"Marwan El","affiliations":["Department of Dental Sciences, Faculty of Medicine, University of Liege, Liege, Belgium"],"ids":["SC:57208147957"}
Namour, Amaury; Department of Dental Sciences, Faculty of Medicine, University of Liege, Liege, Belgium
Namour, Mélanie ; Université de Liège - ULiège > Dental biomaterials research unit (d-BRU)
Romeo, Umberto; Department of Oral and Maxillofacial Sciences, University of Rome "Sapienza", Rome, Italy
España-Tost, Antonio-Jesús; Investigator of the IDIBELL Institute, School of Dentistry, University of Barcelona, Barcelona, Spain
Arnabat-Dominguez, Josep; Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain
Grzech-Lesniak, Kinga; Dental Surgery Department, Medical University of Wroclaw, Wroclaw, Poland
Zeinoun, Toni; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Lebanese University, Beirut, Lebanon
Vescovi, Paolo; Department of Medicine and Surgery, University of Parma, Parma, Italy
Language :
English
Title :
Success Rate of Benign Oral Squamous Papilloma Treatments After Different Surgical Protocols (Conventional, Nd:YAG, CO2 and Diode 980 nm Lasers): A 34-Year Retrospective Study.
Publication date :
February 2021
Journal title :
Photobiomodulation, Photomedicine, and Laser Surgery
2. Sand L, Jalouli J, Larsson PA, Hirsch JM. Human papilloma viruses in oral lesions. Anticancer Res 2000;20:1183-1188.
3. Doorbar J. Host control of human papillomavirus infection and disease. Best Pract Res Clin Obstet Gynaecol 2018;47: 27-41.
4. Munoz N, Castellsagué X, de González AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006;24: 1-10.
5. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-789.
6. Cardoso JC, Calonje E. Cutaneous manifestations of human papillomaviruses: a review. Acta dermatovenerol Alp Pannonica Adriat 2011;20:145-154.
7. Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017;40:80-85.
8. Kaya I, Sivrikoz ON, Etlik O, Gök A. Associations between epidermal growth factor receptor and topoisomerase II-alpha gene copy number variations, human papillomavirus positivity, and cytologic analysis in cervical cell lesions. Indian J Pathol Microbiol 2017;60:328.
9. Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis 2018;18:198-206.
10. Hampras SS, Rollison DE, Giuliano AR, et al. Prevalence and concordance of cutaneous beta human papillomavirus infection at mucosal and cutaneous sites. J infect Dis 2017; 216:92-96.
11. Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res Rev Mutat Res 2017;772:3-12.
12. Acampora A, Grossi A, Barbara A, et al. Increasing HPV vaccination uptake among adolescents: a systematic review. Eur J Public Health 2019;29:185-455.
13. Walker KK, Jackson RD, Sommariva S, Neelamegam M, Desch J. USA dental health providers' role in HPV vaccine communication and HPV-OPC protection: a systematic review. Hum Vaccin Immunother 2019;15: 1863-1869.
14. Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol 2003;192:123-128.
15. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 1996; 82:57-68.
16. Löning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, Zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985;84:417-420.
17. Park NH, Min BM, Li SL, Huang MZ, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991;12:1627-1631.
18. dos Reis HL, Rabelo PC, de Santana MR, Ferreira DC, C Filho A. Oral squamous papilloma and condyloma acumi-natum as manifestations of buccal-genital infection by human papillomavirus. Indian J Sex Transm Dis AIDS 2009; 30:40.
19. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007;107:2-5.
20. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32:16-24.
21. Syrjänen S. Oral manifestations of human papillomavirus infections. Eur J Oral Sci 2018;126:49-66.
22. Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010;37:386-391.
23. Kademani D, Tiwana P. Atlas of Oral and Maxillofacial Surgery. St. Louis, MO: Elsevier Health Sciences, 2015.
24. Betz SJ. HPV-related papillary lesions of the oral mucosa: a review. Head Neck Pathol 2019;13:80-90.
25. Baeder FM, Santos MT, Pelino JE, Duarte DA, Genovese WJ. High-power diode laser versus electrocautery surgery on human papillomavirus lesion treatment. J Craniofac Surg 2012;23:702-705.
26. Aggarwal SP, Aggarwal AK, Aggarwal K. Oral papillo-matosis treated with cryotherapy: a case report. J Dent 1984;12:268-271.
27. Barrellier P, Louis MY, Babin E. The use of cryotherapy in oral pathology. Our experience in 36 cases. Rev Stomatol Chir Maxillofac 1992;93:345-348.
28. Eversole LR. Clinical Outline of Oral Pathology: Diagnosis and Treatment. Shelton, CT: PMPH-USA, 2011.
29. White JM, Chaudhry SI, Kudler JJ, Sekandari N, Schoelch ML, Silverman Jr S. Nd:YAG and CO2 laser therapy of oral mucosal lesions. J Clin Laser Med Surg 1998;16:299-304.
30. Misir AF, Demiriz L, Barut F. Laser treatment of an oral squamous papilloma in a pediatric patient: a case report. J Indian Soc Pedod Prev Dent 2013;31:279.
31. Crockett DM, McGill TJ, Healy GB, Friedman EM. Benign lesions of the nose, oral cavity, and oropharynx in children: excision by carbon dioxide laser. Ann Otol Rhinol Lar-yngol 1985;94:489-493.
32. Yang TH, Lee TH, Huang YC. Oral isotretinoin for treating mucocutaneous human papillomavirus infections: a systematic review and meta-analysis. Indian J Dermatol Ve-nereol Leprol 2019;85:569.
33. Seibert JS, Shannon Jr CJ, Jacoway JR. Treatment of recurrent condyloma acuminatum. Oral Surg Oral Med Oral Pathol 1969;27:398-409.
34. Toledano-Serrabona J, López-Ramírez M, Sánchez-Torres A, Espan a-Tost A, Gay-Escoda C. Recurrence rate of oral squamous cell papilloma after excision with surgical scalpel or laser therapy: a retrospective cohort study. Med Oral Patol Oral Cir Bucal 2019;24:e433.
35. Jaju PP, Suvarna PV, Desai RS. Squamous papilloma: case report and review of literature. Int J Oral Sci 2010;2:222-225.
36. Stojanov IJ, Woo SB. Human papillomavirus and Epstein-Barr virus associated conditions of the oral mucosa. Semin Diagn Pathol 2015;32:3-11.
37. Abbey LM, Page DG, Sawyer DR. The clinical and histo-pathologic features of a series of 464 oral squamous cell papillomas. Oral Surg Oral Med Oral Pathol 1980;49:419-428.
38. Jang JY, Choi N, Ko YH, et al. Differential impact of close surgical margin on local recurrence according to primary tumor size in oral squamous cell carcinoma. Ann Surg Oncol 2017;24:1698-1706.
39. Kurita H, Nakanishi Y, Nishizawa R, et al. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol 2010;46:814-817.
40. Vitruk P. The ideal laser scalpel. In: Laser Surgery in Veterinary Medicine. CJ Winkler (ed.). New York, John Wiley & Sons, Inc., 2019; pp. 32-41.
41. Li W, Zheng J, Zhang Y, Yuan F, Lyu P. Temperature and depth evaluation of the in vitro effects of femtosecond laser on oral soft tissue, with or without air-cooling. Lasers Med Sci 2019;34:649-658.
42. Luna-Ortiz K, Hidalgo-Bahena SC, Mun oz-Gutiérrez TL, Mosqueda-Taylor A. Tumors of the oral cavity: CO2 laser management. Med Oral Patol Oral Cir Bucal 2019;24:e84.
43. Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol 2015;25:2-3.
44. Doorbar J, Egawa N. The low-risk papillomaviruses. Virus Res 2017;231:119-127.
45. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 2018;47:14-26.
47. Münger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78:11451-11460.
48. Lehoux M, D'Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcino-genesis. Public Health Genomics 2009;12:268-280.
49. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16:1-7.
50. Vargis E, Tang YW, Khabele D, Mahadevan-Jansen A. Near-infrared Raman microspectroscopy detects high-risk human papillomaviruses. Transl Oncol 2012;5:172.
51. Reddout N, Christensen T, Bunnell A, et al. High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agents Cancer 2007;2:21.
52. de Sanjose S, Quint WG, Alemany L, et al. Human papil-lomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-1056.
53. De Sanjosé S, Alemany L, Ordi J, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013;49:3450-3461.
54. Bauman J, Wirth L. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OP-SCC) of the head and neck: a growing epidemic. Adolesc Med State Art Rev 2014;25:489.
55. Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital 2014;34:299.
56. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-1435.
57. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008;118:1236-1247.
58. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001;4:68-72.
59. Hanna E, Bachmann G. HPV vaccination with GardasilR: a breakthrough in women's health. Expert Opin Biol Ther 2006;6:1223-1227.
60. Lee SH. Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil". J Inorg Biochem 2012; 117:85-92.
61. Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of Cervarix™ and GardasilR human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 2009;5:705-719.
62. Goeser AL. Quadrivalent HPV recombinant vaccine (Gardasil) for the prevention of cervical cancer. Am Fam Physician 2007;76:573.
63. Zhai L, Tumban E. Gardasil-9: a global survey of projected efficacy. Antiviral Res 2016;130:101-109.
64. DeLong L, Burkhart NW. General and Oral Pathology for the Dental Hygienist. Burlington, VT: Jones & Bartlett Learning, 2020.
65. Doriana AF, Constantin M, Norina F. Surgical lasers: a review of applications in the therapy of oral mucosa lesions. Roman J Oral Rehabil 2020;12:24-31.
66. Nammour S, Zeinoun T, Namour A, Vanheusden A, Ves-covi P. Evaluation of different laser-supported surgical protocols for the treatment of oral leukoplakia: a long-term follow-up. Photomed Laser Surg 2017;35:629-638.
67. Asnaashari M, Zadsirjan S. Application of laser in oral surgery. J Lasers Med Sci 2014;5:97.
68. Nammour S, El Mobadder M, Namour M, et al. A randomized comparative clinical study to evaluate the longevity of esthetic results of gingival melanin depigmentation treatment using different laser wavelengths (diode, CO2, and Er: YAG). Photobiomodul Photomed Laser Surg 2020;38:167-173.
69. Frigerio M, Martinelli-Kläy CP, Lombardi T. Clinical, histopathological and immunohistochemical study of oral squamous papillomas. Acta Odontol Scand 2015;73: 508-515.
70. Orita Y, Gion Y, Tachibana T, et al. Laryngeal squamous cell papilloma is highly associated with human papillo-mavirus. Jap J Clin Oncol 2018;48:350-355.
71. Yazu H, Dogru M, Miyauchi J, et al. Association of epithelial atypia with recurrence after surgical excision in conjunctival papilloma. Eye Contact Lens 2018;44: 77-81.
